|
CH575014A5
(cg-RX-API-DMAC10.html)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
|
JPS5328498Y2
(cg-RX-API-DMAC10.html)
|
1973-08-17 |
1978-07-18 |
|
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
|
RU2151612C1
(ru)
|
1992-12-01 |
2000-06-27 |
Протеин Дизайн Лэбс, Инк. |
Гуманизированный иммуноглобулин, специфичный для белка l-селектина человека
|
|
FR2707189B1
(fr)
|
1993-07-09 |
1995-10-13 |
Gradient Ass |
Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé.
|
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
ES2233974T3
(es)
|
1995-09-11 |
2005-06-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
|
JP4334141B2
(ja)
|
1998-04-20 |
2009-09-30 |
グリカート バイオテクノロジー アクチェンゲゼルシャフト |
抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作
|
|
BR9910568A
(pt)
|
1998-04-30 |
2001-09-11 |
Tanox Inc |
Anticorpos agonistas de receptor de g-csf e processo de seleção para os mesmos
|
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
|
WO1999067290A1
(fr)
|
1998-06-24 |
1999-12-29 |
Chugai Research Institute For Molecular Medicine, Inc. |
Nouvelles proteines receptrices d'hemopoïetine
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
DK1188830T3
(da)
|
1999-06-02 |
2010-04-26 |
Chugai Pharmaceutical Co Ltd |
Nyt hæmopoietinreceptorprotein NR10
|
|
EP1221482B1
(en)
|
1999-09-27 |
2005-12-28 |
Chugai Seiyaku Kabushiki Kaisha |
Hemopoietin receptor protein, nr12
|
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
EP1325115B1
(en)
|
2000-06-26 |
2016-07-27 |
ZymoGenetics, Inc. |
Cytokine receptor zcytor17
|
|
EP1332209B1
(en)
|
2000-09-08 |
2009-11-11 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
|
CA2418835A1
(en)
|
2000-10-16 |
2002-04-25 |
Phylos, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
|
PL366469A1
(en)
|
2001-04-05 |
2005-02-07 |
Immuno-Biological Laboratories Co, Ltd. |
Anti-osteopontin antibody and use thereof
|
|
US20030157561A1
(en)
|
2001-11-19 |
2003-08-21 |
Kolkman Joost A. |
Combinatorial libraries of monomer domains
|
|
WO2004003140A2
(en)
|
2002-01-18 |
2004-01-08 |
Zymogenetics, Inc. |
Cytokine receptor zcytor17 multimers
|
|
RU2490276C2
(ru)
|
2002-01-18 |
2013-08-20 |
Займоджинетикс, Инк. |
Новый лиганд рецептора цитокина zcytor17
|
|
US7303896B2
(en)
|
2002-02-25 |
2007-12-04 |
Genentech, Inc. |
Nucleic acid encoding novel type-1 cytokine receptor GLM-R
|
|
CN100412090C
(zh)
|
2002-05-01 |
2008-08-20 |
舍林股份公司 |
作为抗凝剂的新的靶向组织因子的血栓调节蛋白融合蛋白
|
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
|
KR101230724B1
(ko)
|
2003-03-04 |
2013-02-07 |
알렉시온 파마슈티칼스, 인코포레이티드 |
항원 제공 세포의 내성을 유도함으로써 자가 면역 질환 치료 방법
|
|
DE602004028347D1
(de)
|
2003-03-24 |
2010-09-09 |
Zymogenetics Inc |
Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
|
|
CA2555340A1
(en)
|
2004-02-12 |
2005-09-01 |
Lexicon Genetics Incorporated |
Gene disruptions, compositions and methods relating thereto
|
|
EP1773391A4
(en)
|
2004-06-25 |
2009-01-21 |
Medimmune Inc |
INCREASING THE PRODUCTION OF RECOMBINANT ANTIBODIES IN MAMMALIAN CELLS BY MUTAGENESIS ON THE SITE
|
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
RU2481356C2
(ru)
|
2004-12-28 |
2013-05-10 |
Иннейт Фарма |
Моноклональные антитела против nkg2a
|
|
ES2579758T3
(es)
|
2005-01-28 |
2016-08-16 |
Zymogenetics, Inc. |
Preparaciones homogéneas de IL-31
|
|
EP1858924A1
(en)
|
2005-02-14 |
2007-11-28 |
ZymoGenetics, Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
JP4927762B2
(ja)
|
2005-02-14 |
2012-05-09 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
RU2444528C2
(ru)
|
2005-05-06 |
2012-03-10 |
Займоджинетикс, Инк. |
Моноклональные антитела против il-31 и способы применения
|
|
CN101198624B
(zh)
|
2005-05-06 |
2012-10-10 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体及使用方法
|
|
EP2001906A2
(en)
|
2006-01-10 |
2008-12-17 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
|
|
EP2463305B1
(en)
|
2006-01-12 |
2016-05-11 |
Alexion Pharmaceuticals, Inc. |
Antibodies to OX-2/CD200 and uses thereof
|
|
MY169492A
(en)
|
2006-03-23 |
2019-04-15 |
Bioarctic Neuroscience Ab |
Improved protofibril selective antibodies and the use thereof
|
|
ES2544888T3
(es)
|
2006-06-08 |
2015-09-04 |
Chugai Seiyaku Kabushiki Kaisha |
Prevención o remedio para enfermedades inflamatorias
|
|
US7858756B2
(en)
|
2006-06-15 |
2010-12-28 |
The Board Of Trustees Of The University Of Arkansas |
Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
|
|
EP2061811A2
(en)
|
2006-09-01 |
2009-05-27 |
ZymoGenetics, Inc. |
Variable region sequences of il-31 monoclonal antibodies and methods of use
|
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
|
CA2672215A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
WO2008100995A1
(en)
|
2007-02-14 |
2008-08-21 |
Vaccinex, Inc. |
Humanized anti-cd100 antibodies
|
|
HUE042172T2
(hu)
|
2007-02-23 |
2019-06-28 |
Merck Sharp & Dohme |
Genetikailag elõállított anti-il-23P19 antitestek
|
|
WO2008114733A1
(ja)
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
JP2010531340A
(ja)
|
2007-07-10 |
2010-09-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規処方物
|
|
EP3127921A1
(en)
|
2007-09-26 |
2017-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method of modifying isoelectric point of antibody via amino acid substition in cdr
|
|
ES2687808T3
(es)
|
2007-09-26 |
2018-10-29 |
Chugai Seiyaku Kabushiki Kaisha |
Región constante de anticuerpo modificado
|
|
RU2505603C2
(ru)
|
2007-09-26 |
2014-01-27 |
Чугаи Сейяку Кабусики Кайся |
Антитело против рецептора il-6
|
|
TWI548418B
(zh)
*
|
2007-12-05 |
2016-09-11 |
中外製藥股份有限公司 |
Anti-NR10 / IL-31RA antibody and its use
|
|
CA2708065C
(en)
|
2007-12-05 |
2015-02-24 |
Chugai Seiyaku Kabushiki Kaisha |
Therapeutic agent for pruritus
|
|
SI2796466T1
(en)
|
2007-12-07 |
2018-01-31 |
Zymogenetics, Inc. |
Molecules of Humanized Specifics Specifiable for IL-31
|
|
KR20160062207A
(ko)
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP2010210772A
(ja)
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
|
US8785168B2
(en)
|
2009-06-17 |
2014-07-22 |
Biomarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
JP6176849B2
(ja)
|
2011-07-19 |
2017-08-09 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
CN118286417A
(zh)
|
2012-09-07 |
2024-07-05 |
瑞泽恩制药公司 |
以il-4r拮抗剂治疗特应性皮炎的方法
|
|
WO2014145159A2
(en)
|
2013-03-15 |
2014-09-18 |
Permeon Biologics, Inc. |
Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
|
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
TW201537175A
(zh)
*
|
2013-06-28 |
2015-10-01 |
Chugai Pharmaceutical Co Ltd |
預測罹患具皮膚搔癢之疾病的患者對ｉｌ－３１拮抗劑之治療的反應之方法
|
|
FI3284480T3
(fi)
|
2015-04-14 |
2025-09-11 |
Chugai Pharmaceutical Co Ltd |
IL-31-antagonistia vaikuttavana ainesosana sisältävä farmaseuttinen koostumus atooppisen ihottuman ehkäisemiseksi ja/tai hoitamiseksi
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
|
US10554227B2
(en)
*
|
2017-03-10 |
2020-02-04 |
Western Digital Technologies, Inc. |
Decoding optimization for channel mismatch
|
|
US10493149B2
(en)
|
2017-04-11 |
2019-12-03 |
Kiniksa Pharmaceuticals, Ltd. |
Stable anti-OSMR antibody formulation
|
|
JP7549530B2
(ja)
|
2018-05-21 |
2024-09-11 |
中外製薬株式会社 |
ガラス容器に封入された凍結乾燥製剤
|
|
WO2021100794A1
(ja)
|
2019-11-20 |
2021-05-27 |
中外製薬株式会社 |
抗体含有製剤
|
|
CA3189847A1
(en)
|
2020-09-01 |
2022-03-10 |
Naoki Fukazawa |
Pharmaceutical composition for prevention and/or treatment of dialysis pruritus containing il-31 antagonist as active ingredient
|
|
WO2022113316A1
(ja)
|
2020-11-30 |
2022-06-02 |
マルホ株式会社 |
線維化の進行抑制剤
|
|
WO2023120561A1
(ja)
|
2021-12-22 |
2023-06-29 |
中外製薬株式会社 |
生物活性が低下した抗体バリアント
|